Immunitybio Inc

NASDAQ IBRX

Data sourced from iex and EODHD
Download Data

Immunitybio Inc Income Statement 2014 - 2023

This table shows the Income Statement for Immunitybio Inc going from 2014 until 2023. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Revenue
M 1 0 1 1 2 0 0 0 0 1
Cost of Revenue
M 19 24 - 9 - - - - - 0
Gross Profit
M -18 -24 1 -9 2 0 0 0 0 1
Operating Expenses
M 343 327 331 212 158 96 96 121 237 7
Selling, General, and Administrative Expenses (SG&A)
M 123 103 135 27 18 43 57 95 228 4
Research and Development (R&D) Expenses
M 214 248 196 140 112 56 42 29 11 2
Other Operating Expenses
M 7 -24 0 46 28 -2 -3 -3 -2 1
Costs and Expenses
M 325 327 - 202 - - - - - 6
Operating Income
M -361 -351 -330 -221 -156 -96 -96 -121 -237 -6
Interest Expense
M 129 64 15 9 6 0 1 0 0 0
Non-operating Income/Expense
M -223 -66 -20 -5 -4 0 -1 0 2 -1
EBT
M -584 -417 -350 -226 -160 -97 -97 -121 -237 -6
Income Tax Provision
M 0 0 0 -2 0 -1 0 -1 0 0
Income after Tax
M -584 -417 -350 -224 -160 -96 -96 -121 -237 -6
Non-Controlling Interest
M - -1 -3 37 -69 - - - - -
Net Income
M - -417 -347 -129 -91 -84 -96 -121 - -
Shares (Basic, Weighted)
M - - - - - - - - - -
Shares (Diluted, Weighted)
R 508,635,592.00 399,900,374.00 389,234,156.00 383,179,376.00 383,179,376.00 79,132,220.00 80,583,910.00 81,979,005.00 71,519,609.00 78,931,632.00
EBITDA
M -343 -344 -316 -195 -140 -87 -91 -118 -236 -6
Depreciation and Amortization
M 19 7 14 26 16 10 6 4 1 0
EBIT
M -361 -351 -330 -221 -156 -96 -96 -121 -237 -6
Income from Discontinued Operations
M - - - - - - - - - -
Tax Rate (Effective)
% 0.01 -0.01 0.00 0.82 0.07 0.52 0.51 0.47 0.13 -0.02
Earnings Per Share (EPS), Basic
M - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M - 0 0 0 0 0 0 0 - -
Gross Profit Margin
% -2,876.21 -9,980.00 100.00 -1,411.90 100.00 100.00 100.00 100.00 100.00 100.00
Operating Income Margin
% -58,097.11 -146,374.17 -35,361.88 -36,509.09 -7,095.87 -204,885.11 -213,995.56 -275,715.91 -100,498.73 -969.11
Net Income Margin
% - -173,569.58 -37,129.55 -21,329.09 -4,151.82 -178,659.57 -214,273.33 -274,565.91 - -
EBITDA Ratio
% -55,120.90 -143,324.17 -33,865.52 -32,252.56 -6,356.77 -184,555.32 -201,626.67 -267,518.18 -99,875.00 -949.14
EBIT Ratio
% -58,097.11 -146,374.17 -35,361.88 -36,509.09 -7,095.87 -204,885.11 -213,995.56 -275,715.91 -100,498.73 -969.11
EBT Ratio
% -93,873.31 -173,869.17 -37,456.00 -37,360.83 -7,278.07 -205,806.38 -215,368.89 -275,865.91 -100,498.73 -969.11

StockViz Staff

September 20, 2024

Any question? Send us an email